Zak take - blog22 Oct 2022 17:40
Speaking of pain, the breakdown in life sciences group DeepVerge (DVRG) has been one of the talking points of October to date. This is perhaps over and above the mechanism of how news regarding funding of small-cap companies emerges. Certainly, it maybe useful to read a RNS acknowledging a fundraise if you are short of stock. However, what happens if a rumour of a fundraise is incorrect, or if rumours of a fundraise prevent a company raising cash, when it otherwise would have? The losers in such difficult situations are ordinary shareholders, the winners those who have shorted the stock via murky tip offs, with even murkier motives. https://www.share-talk.com/traders-cafe-with-zak-mir-a-week-in-small-caps-saturday-22nd-october-2022/